Case report: Prolonged amelioration of mild red-green color vision deficiency following psilocybin mushroom use
Brian S. Barnett, Noah Wiles Sweat, Peter S. Hendricks
Drug Science, Policy and Law 2023 DOI: 10.1177/20503245231172536 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A subject with red-green color vision deficiency (mild deuteranomalia) |
| Intervention | Psilocybin mushrooms |
| Dose | 5 g of dried psilocybin mushrooms |
| Duration | At least 16 days post-psilocybin administration |
| Topics | Psilocybin |
| Keywords | Hallucinogen Generalizability theory |
| Citations | 6 |
| Key findings | A single 5 g dose of psilocybin mushrooms produced partial improvement in red-green color vision deficiency that peaked at 8 days and persisted for at least 16 days. |
Abstract
Background: Recent survey data indicate that some people report long-term improvement in color vision deficiency (CVD), also known as color blindness, following use of psychedelics such as lysergic acid diethylamide (LSD) and psilocybin. However, there are no objective data reported in the medical literature quantifying the degree or duration of CVD improvement associated with psychedelic use. Case presentation Here we present the case of a subject with red-green CVD (mild deuteranomalia) who self-administered the Ishihara Test to quantify the degree and duration of CVD improvement following the use of 5 g of dried psilocybin mushrooms. Self-reported Ishihara Test data from the subject revealed partial improvement in CVD peaking at 8 days and persisting for at least 16 days post-psilocybin administration. This improvement may have lasted longer, though the subsequent observations are confounded by additional substance use.
Conclusion: A single use of psilocybin may produce partial improvements in CVD extending beyond the period of acute effect, despite this condition typically resulting from a genetic defect. Systematic exploration of this possible phenomenon is needed to confirm our findings, gauge their generalizability, and determine the mechanism of action.
Comparable studies
Other case reports and case series on psilocybin, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psilocybin Mushroom (Psilocybe semilanceata) Intoxication with Myocardial Infarction 18-year-old man | 1998 | Case study | n = 1 |
| Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF) Person with leg amputation and phantom-limb pain | 2018 | Case study | n = 1 |
| Hallucinogen persisting perception disorder after psilocybin consumption: a case study 18-year-old man with HPPD after mixed psilocybin and cannabis intoxication | 2005 | Case study | n = 1 |
| Microdosing psilocybin for chronic pain: a case series Individuals with chronic neuropathic pain | 2022 | Case series | n = 3 |
| Psilocybin and Obsessive Compulsive Disorder Individual with Obsessive Compulsive Disorder | 2014 | Case study | n = 1 |
Citations in the library
Cited by 4
- Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD Journal of Psychoactive Drugs August 31, 2023
- The psychedelic psilocybin and light exposure have similar and synergistic effects on gene expression patterns in the visual cortex. Molecular Brain March 18, 2025
- Therapeutic Potential of Psychedelics for Treating Anosmia: An Investigation of Online Accounts Journal of Psychoactive Drugs March 1, 2025
- Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global Healthcare Trends in Medical Research June 28, 2024
Cites 18
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology December 1, 2011
- Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis Journal of Humanistic Psychology April 28, 2017
- Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults Clinical Pharmacokinetics March 28, 2017
- Visual Phenomenology of the LSD Flashback Archives of General Psychiatry August 1, 1983
- DARK Classics in Chemical Neuroscience: Psilocybin ACS Chemical Neuroscience June 29, 2018
and 13 more in the library